傲农生物 (603363.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(傲农生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 5,110,026,674.485,248,767,687.474,817,861,444.346,210,478,108.936,585,105,812.134,662,276,066.504,155,179,534.35
 营业收入(元) 5,110,026,674.485,248,767,687.474,817,861,444.346,210,478,108.936,585,105,812.134,662,276,066.504,155,179,534.35
二、营业总成本(元) 5,720,162,823.425,932,253,627.855,132,874,635.396,259,026,969.906,452,297,846.225,097,629,532.144,666,377,006.17
 营业成本(元) 5,285,450,505.175,506,477,969.224,718,079,586.385,767,609,283.745,990,171,199.064,671,044,239.294,235,973,893.25
 研发费用(元) 31,442,417.2134,691,389.6147,317,920.6748,439,093.8041,339,693.5539,256,045.3332,638,151.04
 营业税金及附加(元) 9,100,612.759,369,957.958,881,188.6611,574,547.0112,065,815.828,201,680.238,205,634.33
 销售费用(元) 89,998,321.9893,405,830.9486,407,751.04113,144,940.16111,240,172.8998,827,810.6289,483,038.38
 管理费用(元) 186,184,013.65163,501,645.22148,714,081.85188,907,222.24176,060,693.73144,484,388.08154,190,032.79
 财务费用(元) 117,986,952.66124,806,834.91123,474,106.79129,351,882.95121,420,271.17135,815,368.59145,886,256.38
  其中:利息费用(元) 113,714,973.03122,919,569.23119,161,788.41132,336,998.10117,658,689.85134,477,678.69141,343,743.89
  其中:利息收入(元) 402,523.55473,323.351,202,320.791,548,621.032,097,828.071,314,436.26982,982.31
 资产减值损失(元) -679,114.32---330,609,658.14299,844.29--
 信用减值损失(元) -11,281,324.70-10,757,229.14-19,814,831.72-17,452,251.50-19,875,985.22-28,593,432.17-8,936,025.99
三、其他经营收益
 加:公允价值变动收益(元) ----103,566,981.70---
 加:投资收益(元) 806,287.684,761,301.3436,750,675.31-2,338,322.43-1,744,057.13-5,909,648.34-4,448,421.36
  其中:对联营企业和合营企业的投资收益(元) 1,014,759.54-3,155,107.28-7,469,048.51-25,968.67-195,657.60-4,630,851.11-4,639,523.70
 资产处置收益(元) -6,745,745.363,393,404.131,097,657.313,384,858.55-1,448,931.85737,858.39-118,766.60
 其他收益(元) 58,298,642.1515,266,561.2617,023,247.0234,563,063.179,999,497.4010,796,229.0717,838,324.91
四、营业利润(元) -569,737,403.49-740,527,953.15-279,956,443.13-464,568,153.02118,280,944.25-458,248,191.09-506,862,360.86
 加:营业外收入(元) 21,883,864.3414,900,813.4330,009,628.2213,742,016.7024,354,291.5412,700,580.9410,783,014.94
 减:营业外支出(元) 11,969,908.258,486,096.532,098,049.4722,146,232.2010,661,681.776,491,327.485,918,154.78
五、利润总额(元) -559,823,447.40-734,113,236.25-252,044,864.38-472,972,368.52131,973,554.02-452,038,937.63-501,997,500.70
 减:所得税费用(元) -5,436,946.33-5,472,133.28-1,580,295.25534,611.50-18,315,433.56-34,393,170.19-15,910,607.16
六、净利润(元) -554,386,501.07-728,641,102.97-250,464,569.13-473,506,980.02150,288,987.58-417,645,767.44-486,086,893.54
(一)按经营持续性分类
  持续经营净利润(元) -554,386,501.07-728,641,102.97-250,464,569.13-473,506,980.02150,288,987.58-417,645,767.44-486,086,893.54
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -480,564,513.73-629,610,859.78-179,712,567.24-466,313,682.12104,028,083.90-325,057,172.24-351,683,571.56
  少数股东损益(元) -73,821,987.34-99,030,243.19-70,752,001.89-7,193,297.9046,260,903.68-92,588,595.20-134,403,321.98
 扣除非经常性损益后的净利润(元) -548,130,591.64-655,140,860.65-248,716,371.50-384,728,003.6489,517,263.63-335,706,941.23-368,235,493.95
七、每股收益
 一、基本每股收益(元) -0.56-0.72-0.21-0.580.19-0.41-0.54
 二、稀释每股收益(元) -0.56-0.72-0.21-0.590.18-0.42-0.51
八、其他综合收益(元) 8,523.04-109,894.64-357,359.84-2,649,216.13-890,099.17-372,612.6575,801.65
 归属于母公司股东的其他综合收益(元) 8,523.04-109,894.64-357,359.84-2,649,216.13-890,099.17-372,612.6575,801.65
九、综合收益总额(元) -554,377,978.03-728,750,997.61-250,821,928.97-476,156,196.15149,398,888.41-418,018,380.09-486,011,091.89
 归属于母公司所有者的综合收益总额(元) -480,555,990.69-629,720,754.42-180,069,927.08-468,962,898.25103,137,984.73-325,429,784.89-351,607,769.91
 归属于少数股东的综合收益总额(元) -73,821,987.34-99,030,243.19-70,752,001.89-7,193,297.9046,260,903.68-92,588,595.20-134,403,321.98
公告日期 2023-10-282023-08-312023-04-292023-04-292022-10-292022-08-312022-04-30
审计意见(境内) 标准无保留意见

前瞻产业研究院